Final analysis of potential drug–drug interactions between highly purified cannabidiol and anti‐seizure medications in an open‐label expanded access program

Abstract Objective The aim of this study was to assess potential drug–drug interactions between highly purified cannabidiol (CBD) and anti‐seizure medications (ASMs). Methods Our group previously reported that in a sample of adults and children receiving CBD in an open‐label expanded access program,...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Tyler E. Gaston, E. Martina Bebin, Gary R. Cutter, Leslie Grayson, Jerzy P. Szaflarski
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2023-12-01
Serija:	Epilepsia Open
Teme:	anti‐seizure medications cannabidiol drug interactions treatment‐resistant epilepsy
Online dostop:	https://doi.org/10.1002/epi4.12815
Oznake:	Označite Brez oznak, prvi označite!